Cargando…
Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
Triple-negative breast cancer (TNBC) refers to a group of biologically aggressive breast cancers that do not express estrogen, progesterone or epidermal growth factor receptor 2 hormone receptors. Each subset of TNBC has a unique molecular profile and may require specific treatments. A combination o...
Autores principales: | Mast, Jesse M., Kuppusamy, Periannan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6256245/ https://www.ncbi.nlm.nih.gov/pubmed/30524959 http://dx.doi.org/10.3389/fonc.2018.00527 |
Ejemplares similares
-
Targeted Therapeutic Strategies for Triple-Negative Breast Cancer
por: Li, Ying, et al.
Publicado: (2021) -
Ferroptosis and triple-negative breast cancer: Potential therapeutic targets
por: Xu, Na, et al.
Publicado: (2022) -
Molecular Mechanisms and Emerging Therapeutic Targets of Triple-Negative Breast Cancer Metastasis
por: Neophytou, Christiana, et al.
Publicado: (2018) -
Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens
por: Srivastava, Nityanand, et al.
Publicado: (2023) -
Triple-negative breast cancer: from none to multiple therapeutic targets in two decades
por: Carvalho, Filomena Marino
Publicado: (2023)